These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14879815)

  • 1. [Central stimulant and depressing pyrimidine derivatives].
    JACOB J
    Experientia; 1951 Sep; 7(9):352-3. PubMed ID: 14879815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological classification of central nervous system stimulants. II. Effect of hallucinogenic, psychotonic, analeptic on arousal and depressing mechanisms].
    MONNIER M; KRUPP P
    Arch Int Pharmacodyn Ther; 1960 Sep; 127():337-60. PubMed ID: 13772051
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of two central nervous system stimulants, MER-22 and S.K.F. #5, on chronic blocked and withdrawn psychotic patients.
    HAGENAUER F; RUDY LH; HIMWICH HE
    Am J Psychiatry; 1957 Mar; 113(9):840. PubMed ID: 13402976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analeptics; use and abuse].
    LUKL P
    Prakt Lek; 1952 Aug; 32(15):330-4. PubMed ID: 12983277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with meratran; a new stimulant of the central nervous system].
    FABING HB
    Rev Med Cubana; 1955 Dec; 66(12):923-31. PubMed ID: 13281160
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyrimidine derivatives as potential agents acting on central nervous system.
    Kumar S; Deep A; Narasimhan B
    Cent Nerv Syst Agents Med Chem; 2015; 15(1):5-10. PubMed ID: 25756819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Ethyl-5-(1,3-dimethyl-2-butenyl) barbituric acid, a potent central nervous system stimulant.
    CAIN CK; KLEIS J
    J Med Pharm Chem; 1959 Feb; 1(1):31-6. PubMed ID: 13655027
    [No Abstract]   [Full Text] [Related]  

  • 8. [5-Phenyl-2-imino-4-oxo-oxazolidine, a central stimulant substance].
    SCHMIDT L
    Arzneimittelforschung; 1956 Aug; 6(8):423-6. PubMed ID: 13373635
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties.
    SCHNEIDER JA; SIGG EB
    Ann N Y Acad Sci; 1957 Mar; 66(3):765-76. PubMed ID: 13425258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyrimidine derivatives: their psychotropic properties and the molecular mechanisms of their central action].
    Karkishchenko NN; Makliakov IuS; Stradomskiĭ BV
    Farmakol Toksikol; 1990; 53(4):67-72. PubMed ID: 2171981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological actions of a convulsant barbiturate [sodium 5-ethyl-5-(1, 3-dimethylbutyl) barbiturate]. I. Stimulant and depressant effects.
    DOMINO EF; FOX KE; BRODY TM
    J Pharmacol Exp Ther; 1955 Aug; 114(4):473-83. PubMed ID: 13252566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the psychic effect of a central stimulant after various degrees of psychic stress].
    Janke W; Amelang M
    Psychol Forsch; 1965 Dec; 28(6):562-86. PubMed ID: 4380049
    [No Abstract]   [Full Text] [Related]  

  • 13. Central nervous system stimulants.
    VERNIER VG
    Mod Hosp; 1952 May; 78(5):102-10. PubMed ID: 14940983
    [No Abstract]   [Full Text] [Related]  

  • 14. An apparatus for the study of the effects of central nervous stimulants on the spontaneous activity of small laboratory animals.
    COBBIN LB; LAWSON PT; MCFADYEN R
    Aust J Exp Biol Med Sci; 1955 Oct; 33(5):535-46. PubMed ID: 13283936
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms involved in the interaction of various central stimulants and reserpine.
    SIGG EB; SCHNEIDER JA
    Electroencephalogr Clin Neurophysiol; 1957 Aug; 9(3):419-26. PubMed ID: 13447849
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of the effects of new derivatives of 3-oxo-2,3,5,6,7-8-hexahydro-S-triazolo[4,3-A]pyrimidine on the central nervous system].
    Szadowska A; Graczyk J; Kiełek MB; Kowalczyk K; Pakulska W
    Acta Pol Pharm; 1988; 45(3):288-93. PubMed ID: 3239432
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of the central nervous system.
    Shellenberger MK; Walaszek E
    Prog Neurol Psychiatry; 1970; 25():106-29. PubMed ID: 4395104
    [No Abstract]   [Full Text] [Related]  

  • 18. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of the central nervous system.
    Shellenberger MK; Walaszek EJ
    Prog Neurol Psychiatry; 1972; 27():67-86. PubMed ID: 4145416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ritalin, a new synthetic compound with specific analeptic components].
    MEIER R; GROSS F; TRIPOD J
    Klin Wochenschr; 1954 May; 32(19-20):445-50. PubMed ID: 13164273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.